KLRC2 and acute myeloid leukemia: In post-transplant settings, CMV positivity has been linked to lower relapse rates in acute myeloid leukemia, possibly reflecting immune activation and expansion of adaptive NKG2C+ NK-cell subsets with enhanced cytotoxicity [10-13].